CARE Ratings financials

·Banking & FinanceChart ›
Latest results Q2 FY27 · Jul–Sep 2026
Revenue
₹164cr+20.4% on Q2 FY26
Net profit
₹72.4cr+26.5% on Q2 FY26
EBITDA margin
51.6%+1.4 pts on Q2 FY26
EPS
₹23.88+26.3% on Q2 FY26

Quarterly results

Every quarter ›
₹ croreQ2 FY27Q2 FY26Change
Revenue164136+20.4%
EBITDA84.668.4+23.7%
EBITDA margin51.6%50.2%+1.4 pts
Profit before tax95.676.9+24.3%
Net profit72.457.2+26.5%
EPS₹23.88₹18.90+26.3%

Over time

Q2 FY27 · Jul–Sep 2026latest
Revenue₹164 crNet profit₹72.4 crNet margin44.1%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
4,868————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
22263.148.838.349.4
11.710.79.27.56.8
0.00.00.019.60.0
4,658————
519473402332279
—+17.6%+21.3%+18.9%—
22019715511299.3
42.5%41.7%38.6%33.8%35.6%
20518314410288.8
19517414010385.5
37.7%36.7%34.8%30.9%30.6%
₹64.18₹56.97₹45.67₹33.46₹27.51
—+24.7%+36.5%+21.6%—
—14812390.982.2
—−8.3−14.7−9.2−11.5
13913910881.770.7
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CARERATING₹1,620.20

CARE Ratings Limited

· Banking & Finance
₹ CrorePeersICRAMcap ₹4,868 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————4,868.2
- Cash, Equiv & ST Investments49.438.348.863.1221.7
+ Minority Interest6.87.59.210.711.7
+ Total Debt0.019.60.00.00.0
Enterprise Value————4,658.3
Revenue279.0331.7402.3473.1518.6
Growth %, YoY—+18.9+21.3+17.6—
EBITDA99.3112.1155.3197.4220.3
Margin %35.6133.8138.6141.7342.49
EBIT88.8101.7143.6183.0205.1
Net Income85.5102.6140.0173.7195.3
Margin %30.6330.9234.8036.7237.67
EPS, Adj (current shares)27.5133.4645.6756.9764.18
Growth %, YoY—+21.6+36.5+24.7—
Cash from Operations82.290.9123.0147.7—
Capital Expenditures-11.5-9.2-14.7-8.3—
Free Cash Flow70.781.7108.2139.4139.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

CARE Ratings financials and key ratios

Prices at the previous close · figures from the company's filings with NSE

CARE Ratings (NSE: CARERATING) had a market capitalisation of ₹4,880 crore at the previous close (₹1,620.20 a share), a PE ratio of 25.3 on the last four quarters' profit and a price-to-book ratio of 4.87. In FY26 its consolidated net profit attributable to shareholders was ₹171 crore on revenue of ₹473 crore; in Q2 FY27 (July–September 2026) it was ₹71.8 crore, up 26.8% year on year. It had no borrowings on 30 September 2026.

CARE Ratings Q2 FY27 results
filed 29 October 2026
Share price used
₹1,620.20 · previous close
Latest balance sheet
30 September 2026
Shareholding pattern
30 September 2026

CARE Ratings at a glance · consolidated

Market cap
₹4,880 Crat ₹1,620.20 · previous close
PE ratio (last 4 quarters)
25.328.5 on FY26 profit
Price to book (PB)
4.87book value ₹332.71 a share
ROE (FY26)
19.7%+1.7 pts vs FY25ROCE 19.8%
Debt to equity
0.00net cash ₹295 Cr
FII holding
23.60%+0.2 pts vs 30 Jun 2026no promoter group
Dividend yield
1.36%₹22 a share in 12 months
Net worth
₹1,002 Cr+16.2% vs 30 Sep 202530 September 2026
Free cash flow (FY26)
₹139 Cr+28.8% vs FY25

Questions

What is the CARE Ratings PE ratio today?

CARE Ratings' PE ratio is 25.3 at the previous close (₹1,620.20 a share): a market capitalisation of ₹4,880 crore divided by consolidated net profit attributable to shareholders of ₹193 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit attributable to shareholders (₹171 crore) it is 28.5.

What is the CARE Ratings PB ratio (price to book value)?

CARE Ratings' price-to-book (PB) ratio is 4.87 at the previous close: a market capitalisation of ₹4,880 crore divided by shareholders' equity (book value) of ₹1,002 crore on 30 September 2026. That is a book value of ₹332.71 per share against a share price of ₹1,620.20.

What is the CARE Ratings net worth?

CARE Ratings' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,002 crore on 30 September 2026, up 16.2% from ₹862 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹4,880 crore at the previous close.

What is the CARE Ratings market cap?

CARE Ratings' market capitalisation was ₹4,880 crore at the previous close: 3.01 crore shares at ₹1,620.20 each.

Is CARE Ratings debt free?

Yes. CARE Ratings had no borrowings on 30 September 2026 (consolidated balance sheet), and it held ₹295 crore of cash, bank balances and current investments.

What is the CARE Ratings EPS?

CARE Ratings' basic earnings per share (EPS) were ₹57.06 in FY26, against ₹45.89 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹64.15.

What is the CARE Ratings debt to equity ratio?

CARE Ratings' debt-to-equity ratio was 0.00 on 30 September 2026: no borrowings against total equity of ₹1,014 crore. A year earlier, on 30 September 2025, it was 0.00.

What is the CARE Ratings book value per share?

CARE Ratings' book value per share was ₹332.71 on 30 September 2026: shareholders' equity of ₹1,002 crore divided by the 3.01 crore shares in issue, up 15.7% from ₹287.51 a year earlier. The share price at the previous close was ₹1,620.20.

What is the CARE Ratings promoter holding?

CARE Ratings has no promoter group: on 30 September 2026 promoters held 0% of its shares, according to the shareholding pattern filed with NSE. Foreign portfolio investors held 23.60% and domestic institutions 32.22%.

What is the CARE Ratings ROE and ROCE?

In FY26, CARE Ratings' return on equity (ROE) was 19.7% and its return on capital employed (ROCE) was 19.8%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 18.0% and ROCE 17.7%.

What is the CARE Ratings shareholding pattern?

On 30 September 2026, CARE Ratings' shares were held by foreign portfolio investors (FII/FPI) 23.60%, domestic institutions (DII) 32.22% (including mutual funds at 18.75%) and retail and other non-institutional investors 44.17%. Over the year, FII holding was down 0.01 percentage points from 23.61% and DII holding was up 0.62 percentage points from 31.60%.

How does CARE Ratings compare with its peers?

On FY26 consolidated figures, against ICRA: CARE Ratings' operating margin of 38.7% is the higher of the two (ICRA 31.2%; peer average 31.2%); its return on equity of 19.7% is the higher of the two (ICRA 16.3%; peer average 16.3%); its revenue growth over three years of 19.3% a year is the higher of the two (ICRA 14.1% a year; peer average 14.1% a year).

What is the CARE Ratings dividend yield?

CARE Ratings' dividend yield is 1.36% at the previous close: dividends of ₹22 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹1,620.20. They were ₹14 on 25 June 2026 and ₹8 on 19 November 2025 (interim).

What is the CARE Ratings dividend in 2026 and its record date?

In 2026, CARE Ratings has declared two dividends totalling ₹24 a share: ₹14 with record date 26 June 2026 and ex-date 25 June 2026 and ₹10 (interim) with record date 6 November 2026.

What is the CARE Ratings free cash flow?

In FY26, CARE Ratings generated ₹148 crore of cash from operations and spent ₹8.3 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹139 crore. In FY25 it was ₹108 crore.

What are the CARE Ratings latest quarterly results?

CARE Ratings' latest results are for Q2 FY27 (July–September 2026), filed on 29 October 2026: consolidated net profit attributable to shareholders ₹71.8 crore, up 26.8% from ₹56.7 crore in Q2 FY26; revenue from operations ₹164 crore, up 20.4% year on year.

What is the CARE Ratings revenue and profit in FY26?

In FY26 (April 2025–March 2026), CARE Ratings' consolidated net profit attributable to shareholders was ₹171 crore, up 24.7% from ₹137 crore in FY25, on revenue from operations of ₹473 crore (up 17.6%). Over three years, from FY23, net profit was up 107.1%.

When are the CARE Ratings next results?

CARE Ratings has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.

CARE Ratings vs ICRA: how do they compare?

In FY26, CARE Ratings earned net profit attributable to shareholders of ₹171 crore on revenue of ₹473 crore, against ₹182 crore on ₹600 crore for ICRA. CARE Ratings' operating margin was 38.7% (ICRA 31.2%) and its return on equity 19.7% (ICRA 16.3%).

Where do these CARE Ratings figures come from?

From CARE Ratings' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.